LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 39 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,991 | +2.4% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $1,944 | -99.9% | 2,000,000 | 0.0% | 0.01% | -12.5% |
Q3 2022 | $1,940,000 | -0.3% | 2,000,000 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $1,946,000 | -0.5% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $1,955,000 | -2.5% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $2,006,000 | +0.5% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $1,997,000 | +1.2% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $1,973,000 | -4.1% | 2,000,000 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $2,057,000 | +8.7% | 2,000,000 | 0.0% | 0.01% | -11.1% |
Q4 2020 | $1,893,000 | +3.8% | 2,000,000 | 0.0% | 0.01% | -10.0% |
Q3 2020 | $1,823,000 | +4.5% | 2,000,000 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $1,745,000 | +5.1% | 2,000,000 | 0.0% | 0.01% | -14.3% |
Q1 2020 | $1,661,000 | -3.7% | 2,000,000 | 0.0% | 0.01% | +16.7% |
Q4 2019 | $1,725,000 | +3.9% | 2,000,000 | 0.0% | 0.01% | -7.7% |
Q3 2019 | $1,661,000 | -73.5% | 2,000,000 | -72.7% | 0.01% | -74.5% |
Q2 2019 | $6,278,000 | – | 7,330,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 70,062,000 | $61,167,000 | 7.51% |
SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $15,668,000 | 5.06% |
Context Capital Management, LLC | 6,350,000 | $5,569,000 | 2.17% |
CANYON CAPITAL ADVISORS LLC | 60,000,000 | $52,680,000 | 1.76% |
Opti Capital Management, LP | 8,500 | $7,400,000 | 1.26% |
III Capital Management | 5,000,000 | $4,365,000 | 1.08% |
FALCON POINT CAPITAL, LLC | 250,000 | $219,000 | 1.07% |
Venator Capital Management Ltd. | 1,500,000 | $1,308,000 | 0.86% |
ADVENT CAPITAL MANAGEMENT /DE/ | 30,500,000 | $26,576,000 | 0.62% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,733,000 | 0.48% |